Serologicals Corporation

Patent issued for purification process that reduces the mad cow prions

Published in Medical Patent Business Week, July 2nd, 2004

Serologicals Corporation (SERO) announced that the U.S. Patent Office has issued the patent on its proprietary purification process that inactivates infectious prions in its bovine-based EX-CYTE, a cell culture growth medium.

Prions are defective proteins that cause mad cow disease. The patent, U.S. Patent No. 6,743,899, will remain in force until 2021.

Serologicals Corporation developed the patented process and is the first and only company to incorporate it into production.

"We adhere to the most stringent standards of safety, such as using raw materials from younger cattle, using beef not dairy cows, sourcing animals from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week

Source: Medical Patent Business Week (2004-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry